This company has been marked as potentially delisted and may not be actively trading. HeartBeam (BEAT) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesShort InterestTrendsBuy This Stock BEAT vs. KRMD, AMWL, EUDA, LUNG, MDXH, CCLD, IPA, ZEPP, YI, and PIIIShould you be buying HeartBeam stock or one of its competitors? The main competitors of HeartBeam include KORU Medical Systems (KRMD), American Well (AMWL), EUDA Health (EUDA), Pulmonx (LUNG), MDxHealth (MDXH), CareCloud (CCLD), ImmunoPrecise Antibodies (IPA), Zepp Health (ZEPP), 111 (YI), and P3 Health Partners (PIII). These companies are all part of the "medical info sys" industry. HeartBeam vs. Its Competitors KORU Medical Systems American Well EUDA Health Pulmonx MDxHealth CareCloud ImmunoPrecise Antibodies Zepp Health 111 P3 Health Partners KORU Medical Systems (NASDAQ:KRMD) and HeartBeam (NASDAQ:BEAT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation. Which has preferable earnings & valuation, KRMD or BEAT? KORU Medical Systems has higher revenue and earnings than HeartBeam. KORU Medical Systems is trading at a lower price-to-earnings ratio than HeartBeam, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKORU Medical Systems$33.65M4.77-$6.07M-$0.11-31.64HeartBeamN/AN/A-$19.45M-$0.68-1.82 Does the media favor KRMD or BEAT? In the previous week, KORU Medical Systems had 1 more articles in the media than HeartBeam. MarketBeat recorded 3 mentions for KORU Medical Systems and 2 mentions for HeartBeam. KORU Medical Systems' average media sentiment score of 0.62 beat HeartBeam's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HeartBeam 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is KRMD or BEAT more profitable? HeartBeam has a net margin of 0.00% compared to KORU Medical Systems' net margin of -15.09%. KORU Medical Systems' return on equity of -30.43% beat HeartBeam's return on equity.Company Net Margins Return on Equity Return on Assets KORU Medical Systems-15.09% -30.43% -19.41% HeartBeam N/A -358.33%-278.76% Do insiders and institutionals believe in KRMD or BEAT? 58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 7.8% of HeartBeam shares are held by institutional investors. 20.6% of KORU Medical Systems shares are held by insiders. Comparatively, 18.0% of HeartBeam shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, KRMD or BEAT? KORU Medical Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, HeartBeam has a beta of -0.7, suggesting that its stock price is 170% less volatile than the S&P 500. Do analysts recommend KRMD or BEAT? KORU Medical Systems presently has a consensus target price of $4.50, suggesting a potential upside of 29.31%. HeartBeam has a consensus target price of $8.00, suggesting a potential upside of 547.77%. Given HeartBeam's higher possible upside, analysts clearly believe HeartBeam is more favorable than KORU Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00HeartBeam 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryKORU Medical Systems beats HeartBeam on 12 of the 14 factors compared between the two stocks. Get HeartBeam News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BEAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BEAT vs. The Competition Export to ExcelMetricHeartBeamMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$42.94M$2.00B$5.61B$9.11BDividend YieldN/AN/A5.24%4.01%P/E RatioN/A18.7019.7619.92Price / SalesN/A15.80430.8999.65Price / CashN/A56.3037.4658.16Price / Book20.588.368.045.49Net Income-$19.45M-$62.39M$3.18B$250.27M HeartBeam Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BEATHeartBeam1.6389 of 5 stars$1.24-40.9%$8.00+547.8%-56.9%$42.94MN/A0.001,700Gap UpKRMDKORU Medical Systems2.76 of 5 stars$3.80+3.5%$4.50+18.4%+49.2%$175.33M$33.65M-34.5580AMWLAmerican Well1.9204 of 5 stars$8.60+5.4%$9.67+12.4%+27.2%$134.25M$254.36M-0.841,040EUDAEUDA Health1.3594 of 5 stars$3.35+0.6%N/A-13.7%$124.47M$4.01M0.002LUNGPulmonx3.605 of 5 stars$2.73+3.4%$11.53+322.2%-58.3%$109.91M$83.79M-1.90250MDXHMDxHealth2.1572 of 5 stars$2.18+1.9%$6.50+198.2%-22.4%$103.09M$90.05M-1.90300CCLDCareCloud1.6624 of 5 stars$2.42+2.5%$2.50+3.3%+22.2%$102.42M$112.51M-11.003,650News CoverageIPAImmunoPrecise Antibodies3.0921 of 5 stars$1.76+8.0%$4.00+127.3%+69.4%$80.54M$18.16M-1.5280Positive NewsUpcoming EarningsGap DownZEPPZepp Health2.9667 of 5 stars$5.12+47.1%$13.87+170.9%+146.0%$74.24M$182.60M-1.021,230Gap UpHigh Trading VolumeYI1110.2226 of 5 stars$7.27-2.9%N/A-26.1%$62.81M$1.97B-11.362,110News CoveragePIIIP3 Health Partners2.9207 of 5 stars$6.10-4.7%$16.25+166.4%-74.8%$43.85M$1.49B-0.13500Positive News Related Companies and Tools Related Companies KORU Medical Systems Alternatives American Well Alternatives EUDA Health Alternatives Pulmonx Alternatives MDxHealth Alternatives CareCloud Alternatives ImmunoPrecise Antibodies Alternatives Zepp Health Alternatives 111 Alternatives P3 Health Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BEAT) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartBeam, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartBeam With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BEAT Stock Alerts